PPT-Disclosure Statement of Financial Interest

I John Buckley DO NOT have a financial interestarrangement or affiliation with any healthcare related companies that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation. Christy Hooper, CPA . Assistant Vice Chancellor for University Affairs and Athletics. Shannon Ontiveros, MS. Director, Faculty Training and Compliance Programs. Vanderbilt School of Medicine. Background on Conflict of Interest. Compliance & Conflict of Interest. for Researchers Briefing (COIR). Course Content © 2012 Copyright The Regents of the University of California - All Rights Reserved.. Some graphics copyright © 2009 Microsoft Corporation.. Understand . the importance of disclosure from a business perspective.. Review . the full disclosure principle and describe problems of implementation.. Explain . the use of accounting policy notes in financial statement preparation.. Disclosure Statement of Financial Interest I, (Koji Ikeda) DO NOT have a financial interest/arrangement or affiliation with one or more organizations that could be perceived as a real or apparent conf Guidelines. Presenting . Authors must fully disclose to ARVO and the session participants all commercial relationships relevant to the subject matter for all authors of the presentation and their spouse or partner for the prior 24 months. . Randy Finden . Senior Project Manager. Governmental Accounting Standards Board. The views expressed in this presentation are those of Mr. Finden. Official positions of the GASB on accounting matters are reached only after extensive due process and deliberation.. GML Article 18, and Decisional Law Relating to Conflicts of Interest and Ethics. Presented by: Mark Stevens. Senior Attorney . OSC, Division of Legal Services. Structure and Scope of Article 18. 2011 Revised Regulation. FCOI Webinar for Grantees. Provided by the National Institutes of Health. November 30, 2011. Financial Conflict of Interest (FCOI) 2011 Revised Regulation. Stephen R. Marder, M.D.. Disclosure Information for. Stephen R. Marder, MD. Advisory board. Abbott; Amgen; Roche; Shire; Otsuka America Pharmaceutical, Inc.; Wyeth; Pfizer, . Research Support. Novartis; Glaxo Smith Kline; Sunovion; Psychogenics. Stephen R. Marder, M.D.. Disclosure Information for. Stephen R. Marder, MD. Advisory board. Abbott; Amgen; Roche; Shire; Otsuka America Pharmaceutical, Inc.; Wyeth; Pfizer, . Research Support. Novartis; Glaxo Smith Kline; Sunovion; Psychogenics. Faculty Disclosure Information Elements. Name Of Faculty. Title Of Presentation. Name Of Commercial Interest. Information About Nature Of Relationship, Financial Disclosure Means The Role They Play Or Service They Provide In Exchange For Some Form Of Compensation (E.G., Employment, Management Position, Independent Contractor Including Contracted Research, Consulting, Speaking And Teaching, Membership On Advisory Committees Or Review Panels And Board Membership). . Paul Adams. Stefan Hunt. Redis. . Zaliauskas. Financial Conduct Authority. Christopher Palmer. UC Berkeley. CFPB Research Conference. December 2016. The views expressed herein do not necessarily represent the official position of the FCA.. Please read ACCME’s rule regarding standards for commercial support:. Standard 4.3: Educational materials that are part of a CME activity, such as slides, abstracts and handouts, cannot contain any advertising, corporate logo, trade name or a... Interest Policy. Disclosure of Financial Interest Policy. Medical Staff Policy Approved by the MEC’s. Aimed at protecting the integrity of . Lee . Health Medical Staffs. Requires . disclosure of certain financial interests at the time of...